Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 5
1987 3
1988 4
1990 6
1991 5
1992 3
1993 1
1994 2
1995 1
1996 4
1997 3
1998 3
1999 3
2000 2
2001 1
2003 3
2004 1
2005 5
2006 2
2007 4
2008 9
2009 14
2010 4
2011 10
2012 13
2013 11
2014 13
2015 12
2016 22
2017 18
2018 19
2019 20
2020 22
2021 20
2022 19
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees.
Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenz… See abstract for full author list ➔ Witjes JA, et al. Among authors: valdagni r. Eur Urol. 2020 Feb;77(2):223-250. doi: 10.1016/j.eururo.2019.09.035. Epub 2019 Nov 19. Eur Urol. 2020. PMID: 31753752 Free article.
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types.
Naderi E, Aguado-Barrera ME, Schack LMH, Dorling L, Rattay T, Fachal L, Summersgill H, Martínez-Calvo L, Welsh C, Dudding T, Odding Y, Varela-Pazos A, Jena R, Thomson DJ, Steenbakkers RJHM, Dennis J, Lobato-Busto R, Alsner J, Ness A, Nutting C, Gómez-Caamaño A, Eriksen JG, Thomas SJ, Bates AM, Webb AJ, Choudhury A, Rosenstein BS, Taboada-Valladares B, Herskind C, Azria D, Dearnaley DP, de Ruysscher D, Sperk E, Hall E, Stobart H, Chang-Claude J, De Ruyck K, Veldeman L, Altabas M, De Santis MC, Farcy-Jacquet MP, Veldwijk MR, Sydes MR, Parliament M, Usmani N, Burnet NG, Seibold P, Symonds RP, Elliott RM, Bultijnck R, Gutiérrez-Enríquez S, Mollà M, Gulliford SL, Green S, Rancati T, Reyes V, Carballo A, Peleteiro P, Sosa-Fajardo P, Parker C, Fonteyne V, Johnson K, Lambrecht M, Vanneste B, Valdagni R, Giraldo A, Ramos M, Diergaarde B, Liu G, Leal SM, Chua MLK, Pring M, Overgaard J, Cascallar-Caneda LM, Duprez F, Talbot CJ, Barnett GC, Dunning AM, Vega A, Andreassen CN, Langendijk JA, West CML, Alizadeh BZ, Kerns SL; Radiogenomics Consortium. Naderi E, et al. Among authors: valdagni r. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad088. doi: 10.1093/jncics/pkad088. JNCI Cancer Spectr. 2023. PMID: 37862240 Free PMC article.
Malignant melanoma.
de Braud F, Khayat D, Kroon BB, Valdagni R, Bruzzi P, Cascinelli N. de Braud F, et al. Among authors: valdagni r. Crit Rev Oncol Hematol. 2003 Jul;47(1):35-63. doi: 10.1016/s1040-8428(02)00077-x. Crit Rev Oncol Hematol. 2003. PMID: 12853098 Review.
Predicting toxicity in radiotherapy for prostate cancer.
Landoni V, Fiorino C, Cozzarini C, Sanguineti G, Valdagni R, Rancati T. Landoni V, et al. Among authors: valdagni r. Phys Med. 2016 Mar;32(3):521-32. doi: 10.1016/j.ejmp.2016.03.003. Epub 2016 Apr 8. Phys Med. 2016. PMID: 27068274 Review.
ECCO Essential Requirements for Quality Cancer Care: Prostate cancer.
Brausi M, Hoskin P, Andritsch E, Banks I, Beishon M, Boyle H, Colecchia M, Delgado-Bolton R, Höckel M, Leonard K, Lövey J, Maroto P, Mastris K, Medeiros R, Naredi P, Oyen R, de Reijke T, Selby P, Saarto T, Valdagni R, Costa A, Poortmans P. Brausi M, et al. Among authors: valdagni r. Crit Rev Oncol Hematol. 2020 Apr;148:102861. doi: 10.1016/j.critrevonc.2019.102861. Epub 2020 Jan 7. Crit Rev Oncol Hematol. 2020. PMID: 32151466 Review.
Active surveillance for low-risk prostate cancer.
Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll PR, Denis LJ, Parker C, Roobol MJ, Emberton M, Klotz LH, Rannikko A, Kakehi Y, Lane JA, Schröder FH, Semjonow A, Trock BJ, Valdagni R. Bangma CH, et al. Among authors: valdagni r. Crit Rev Oncol Hematol. 2013 Mar;85(3):295-302. doi: 10.1016/j.critrevonc.2012.07.005. Epub 2012 Aug 9. Crit Rev Oncol Hematol. 2013. PMID: 22878262 Review.
Multipeptide vaccination in cancer patients.
Pilla L, Rivoltini L, Patuzzo R, Marrari A, Valdagni R, Parmiani G. Pilla L, et al. Among authors: valdagni r. Expert Opin Biol Ther. 2009 Aug;9(8):1043-55. doi: 10.1517/14712590903085109. Expert Opin Biol Ther. 2009. PMID: 19591629 Review.
miRNAs in tumor radiation response: bystanders or participants?
Gandellini P, Rancati T, Valdagni R, Zaffaroni N. Gandellini P, et al. Among authors: valdagni r. Trends Mol Med. 2014 Sep;20(9):529-39. doi: 10.1016/j.molmed.2014.07.004. Epub 2014 Aug 18. Trends Mol Med. 2014. PMID: 25153824 Review.
The emerging role of PARP inhibitors in prostate cancer.
Stellato M, Guadalupi V, Sepe P, Mennitto A, Claps M, Zattarin E, Verzoni E, Valdagni R, De Braud FG, Santini D, Tonini G, Procopio G. Stellato M, et al. Among authors: valdagni r. Expert Rev Anticancer Ther. 2020 Aug;20(8):715-726. doi: 10.1080/14737140.2020.1797497. Epub 2020 Aug 6. Expert Rev Anticancer Ther. 2020. PMID: 32758032 Review.
254 results